The performance of the global muscle stimulation devices market is expected to witness immensely impactful developments with potential improvements in the recovery of stroke through nerve stimulation.
With rising rates of acute ischemic stroke (AIS), the focus has been shifted to improving the associated stages of stroke care, including prevention, intervention and rehabilitation. The Ohio State University has been conducting a new clinical trial to shorten the motor skills recovery period in stroke patients via vagus nerve stimulation (VNS).
The trial involves the use of the Vivistim device, which has been developed by MicroTransponder. The device functions by coupling VNS with the muscle movement during rehabilitation. It is supposed to build up the motor function, learning and memory, thereby drastically improving the post-stroke outcome.
If used in tandem with appropriate interventions, this nerve stimulation therapy can potentially result in excellent rehabilitation and minimise the impact of complications that may follow the treatment process. If Vivistim delivers positive results and enables stroke patients to regain their motor function early, the market participants may witness multiple doors of opportunities in the rehabilitative treatment area.
Key companies to focus on strong distribution channel development and suppliers to strengthen presence in emerging markets
New and innovative product launches such as wireless devices are being considered by manufacturers as the key to achieving enhanced device capabilities, which is presumed to trigger sales in the long term.
To expand market shares and improve the distribution network over the next decade, several players are prioritising strategic partnerships such as distribution agreements for their product offerings. Enhanced distribution will also help the stakeholders penetrate various untapped regional markets.
Key players in the global muscle stimulation devices market are focusing on the development of new pain management methods and techniques. Adoption of innovative marketing strategy by muscle stimulation device manufacturers is attributed to their gradually increasing market value share.
Increased focus on strengthening of the distribution channel will reportedly be the key for market expansion in emerging economies. On the flipside, suppliers are likely to consider patients’ needs as a top priority, while ensuring the supply of high-quality products to end users.
Stakeholders are strengthening the product portfolio by launching new products with improved features, and through strategic mergers and acquisitions. Moreover, a growing number of local players in the muscle stimulation devices market is expected to result in creating a fragmented market, since the market is already led by smaller-sized firms catering to domestic customer demands.
Muscle stimulation devices to face passive growth
Despite immense scope for innovation in product development and applications, the global market for muscle stimulation devices is projected to observe sluggish growth over the next decade.
As prompted by a recent research study by Future Market Insights, the global muscle stimulation devices market will expand at a compound annual growth rate (CAGR) of 3.9% during the 2018-2028 period, attaining a value of more than $870m by the end of 2028. High price points will remain a longstanding factor, limiting widespread adoption of muscle stimulators.
Stringent regulatory norms regarding the launch and use of muscle stimulation devices are also anticipated to hinder market growth in the upcoming decade.
To request a sample report, click here.
To find out more information about report methodology, click here.